Pharma and Biotech
Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -531.0% | n/a |
ROCE | 38962.2% |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 8.2 | n/a |
Pr/Book | 2.4 |
Latest | F'cast | |
---|---|---|
Revenue | 8.3% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | 0.52 | (0.45) | (0.65)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 0.22 | (0.95) | (1.36)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 0.54 | (2.70) | (2.61)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | 0.59 | (3.12) | (3.00)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Proposed acquisition of Awakn Life Sciences Corp | 16-Dec-2024 | 07:00 | RNS |
Initial Results University of Nottingham | 11-Dec-2024 | 07:00 | RNS |
Notice of GM and proposed name change | 03-Dec-2024 | 09:44 | RNS |
Graft Polymer to buy Awakn in £4.98m deal | 16-Dec-2024 | ShareCast |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 0.21p |
Change Today | 0.005p |
% Change | 2.44 % |
52 Week High | 1.01 |
52 Week Low | 0.12 |
Volume | 9,900,763 |
Shares Issued | 2,295.93m |
Market Cap | £4.82m |
Beta | 1.28 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
10:54 | 149,019 @ 0.20p |
08:20 | 6,500,000 @ 0.21p |
10:07 | 251,744 @ 0.20p |
08:20 | 3,000,000 @ 0.21p |
CEO | Anthony Tennyson |
Chair | Dennis Purcell |
You are here: research